Global Drugs of Abuse Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

TABLE OF CONTENTS

1 Market Overview

• 1.1 Drugs of Abuse Testing Product Scope
• 1.2 Drugs of Abuse Testing by Type
  • 1.2.1 Global Drugs of Abuse Testing Sales by Type (2020 & 2024 & 2031)
  • 1.2.2 Urine Testing
  • 1.2.3 Saliva Testing
  • 1.2.4 Blood Testing
  • 1.2.5 Hair and Sweat Testing
  • 1.2.6 Others
• 1.3 Drugs of Abuse Testing by Application
  • 1.3.1 Global Drugs of Abuse Testing Sales Comparison by Application (2020 & 2024 & 2031)
  • 1.3.2 Hospital
  • 1.3.3 Law Enforcement
  • 1.3.4 Drug Treatment Center
  • 1.3.5 Laboratory
  • 1.3.6 Others
• 1.4 Global Drugs of Abuse Testing Market Estimates and Forecasts (2020-2031)
  • 1.4.1 Global Drugs of Abuse Testing Market Size in Value Growth Rate (2020-2031)
  • 1.4.2 Global Drugs of Abuse Testing Market Size in Volume Growth Rate (2020-2031)
  • 1.4.3 Global Drugs of Abuse Testing Price Trends (2020-2031)
• 1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

• 2.1 Global Drugs of Abuse Testing Market Size by Region: 2020 VS 2024 VS 2031
• 2.2 Global Drugs of Abuse Testing Retrospective Market Scenario by Region (2020-2025)
  • 2.2.1 Global Drugs of Abuse Testing Sales Market Share by Region (2020-2025)
  • 2.2.2 Global Drugs of Abuse Testing Revenue Market Share by Region (2020-2025)
• 2.3 Global Drugs of Abuse Testing Market Estimates and Forecasts by Region (2026-2031)
  • 2.3.1 Global Drugs of Abuse Testing Sales Estimates and Forecasts by Region (2026-2031)
  • 2.3.2 Global Drugs of Abuse Testing Revenue Forecast by Region (2026-2031)
• 2.4 Major Region and Emerging Market Analysis
  • 2.4.1 North America Drugs of Abuse Testing Market Size and Prospective (2020-2031)
  • 2.4.2 Europe Drugs of Abuse Testing Market Size and Prospective (2020-2031)
  • 2.4.3 China Drugs of Abuse Testing Market Size and Prospective (2020-2031)
  • 2.4.4 Japan Drugs of Abuse Testing Market Size and Prospective (2020-2031)

3 Global Market Size by Type

• 3.1 Global Drugs of Abuse Testing Historic Market Review by Type (2020-2025)
  • 3.1.1 Global Drugs of Abuse Testing Sales by Type (2020-2025)
  • 3.1.2 Global Drugs of Abuse Testing Revenue by Type (2020-2025)
  • 3.1.3 Global Drugs of Abuse Testing Price by Type (2020-2025)
• 3.2 Global Drugs of Abuse Testing Market Estimates and Forecasts by Type (2026-2031)
  • 3.2.1 Global Drugs of Abuse Testing Sales Forecast by Type (2026-2031)
  • 3.2.2 Global Drugs of Abuse Testing Revenue Forecast by Type (2026-2031)
  • 3.2.3 Global Drugs of Abuse Testing Price Forecast by Type (2026-2031)
• 3.3 Different Types Drugs of Abuse Testing Representative Players

4 Global Market Size by Application

• 4.1 Global Drugs of Abuse Testing Historic Market Review by Application (2020-2025)
  • 4.1.1 Global Drugs of Abuse Testing Sales by Application (2020-2025)
  • 4.1.2 Global Drugs of Abuse Testing Revenue by Application (2020-2025)
  • 4.1.3 Global Drugs of Abuse Testing Price by Application (2020-2025)
• 4.2 Global Drugs of Abuse Testing Market Estimates and Forecasts by Application (2026-2031)
  • 4.2.1 Global Drugs of Abuse Testing Sales Forecast by Application (2026-2031)
  • 4.2.2 Global Drugs of Abuse Testing Revenue Forecast by Application (2026-2031)
  • 4.2.3 Global Drugs of Abuse Testing Price Forecast by Application (2026-2031)
• 4.3 New Sources of Growth in Drugs of Abuse Testing Application

5 Competition Landscape by Players

• 5.1 Global Drugs of Abuse Testing Sales by Players (2020-2025)
• 5.2 Global Top Drugs of Abuse Testing Players by Revenue (2020-2025)
• 5.3 Global Drugs of Abuse Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Abuse Testing as of 2024)
• 5.4 Global Drugs of Abuse Testing Average Price by Company (2020-2025)
• 5.5 Global Key Manufacturers of Drugs of Abuse Testing, Manufacturing Sites & Headquarters
• 5.6 Global Key Manufacturers of Drugs of Abuse Testing, Product Type & Application
• 5.7 Global Key Manufacturers of Drugs of Abuse Testing, Date of Enter into This Industry
• 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

• 6.1 North America Market: Players, Segments, Downstream and Major Customers
  • 6.1.1 North America Drugs of Abuse Testing Sales by Company
    • 6.1.1.1 North America Drugs of Abuse Testing Sales by Company (2020-2025)
    • 6.1.1.2 North America Drugs of Abuse Testing Revenue by Company (2020-2025)
  • 6.1.2 North America Drugs of Abuse Testing Sales Breakdown by Type (2020-2025)
  • 6.1.3 North America Drugs of Abuse Testing Sales Breakdown by Application (2020-2025)
  • 6.1.4 North America Drugs of Abuse Testing Major Customer
  • 6.1.5 North America Market Trend and Opportunities
• 6.2 Europe Market: Players, Segments, Downstream and Major Customers
  • 6.2.1 Europe Drugs of Abuse Testing Sales by Company
    • 6.2.1.1 Europe Drugs of Abuse Testing Sales by Company (2020-2025)
    • 6.2.1.2 Europe Drugs of Abuse Testing Revenue by Company (2020-2025)
  • 6.2.2 Europe Drugs of Abuse Testing Sales Breakdown by Type (2020-2025)
  • 6.2.3 Europe Drugs of Abuse Testing Sales Breakdown by Application (2020-2025)
  • 6.2.4 Europe Drugs of Abuse Testing Major Customer
  • 6.2.5 Europe Market Trend and Opportunities
• 6.3 China Market: Players, Segments, Downstream and Major Customers
  • 6.3.1 China Drugs of Abuse Testing Sales by Company
    • 6.3.1.1 China Drugs of Abuse Testing Sales by Company (2020-2025)
    • 6.3.1.2 China Drugs of Abuse Testing Revenue by Company (2020-2025)
  • 6.3.2 China Drugs of Abuse Testing Sales Breakdown by Type (2020-2025)
  • 6.3.3 China Drugs of Abuse Testing Sales Breakdown by Application (2020-2025)
  • 6.3.4 China Drugs of Abuse Testing Major Customer
  • 6.3.5 China Market Trend and Opportunities
• 6.4 Japan Market: Players, Segments, Downstream and Major Customers
  • 6.4.1 Japan Drugs of Abuse Testing Sales by Company
    • 6.4.1.1 Japan Drugs of Abuse Testing Sales by Company (2020-2025)
    • 6.4.1.2 Japan Drugs of Abuse Testing Revenue by Company (2020-2025)
  • 6.4.2 Japan Drugs of Abuse Testing Sales Breakdown by Type (2020-2025)
  • 6.4.3 Japan Drugs of Abuse Testing Sales Breakdown by Application (2020-2025)
  • 6.4.4 Japan Drugs of Abuse Testing Major Customer
  • 6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

• 7.1 Abbott
  • 7.1.1 Abbott Company Information
  • 7.1.2 Abbott Business Overview
  • 7.1.3 Abbott Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.1.4 Abbott Drugs of Abuse Testing Products Offered
  • 7.1.5 Abbott Recent Development
• 7.2 Thermo Fisher
  • 7.2.1 Thermo Fisher Company Information
  • 7.2.2 Thermo Fisher Business Overview
  • 7.2.3 Thermo Fisher Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.2.4 Thermo Fisher Drugs of Abuse Testing Products Offered
  • 7.2.5 Thermo Fisher Recent Development
• 7.3 Roche
  • 7.3.1 Roche Company Information
  • 7.3.2 Roche Business Overview
  • 7.3.3 Roche Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.3.4 Roche Drugs of Abuse Testing Products Offered
  • 7.3.5 Roche Recent Development
• 7.4 Siemens Healthineers
  • 7.4.1 Siemens Healthineers Company Information
  • 7.4.2 Siemens Healthineers Business Overview
  • 7.4.3 Siemens Healthineers Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.4.4 Siemens Healthineers Drugs of Abuse Testing Products Offered
  • 7.4.5 Siemens Healthineers Recent Development
• 7.5 Wondfo Biotech
  • 7.5.1 Wondfo Biotech Company Information
  • 7.5.2 Wondfo Biotech Business Overview
  • 7.5.3 Wondfo Biotech Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.5.4 Wondfo Biotech Drugs of Abuse Testing Products Offered
  • 7.5.5 Wondfo Biotech Recent Development
• 7.6 Randox
  • 7.6.1 Randox Company Information
  • 7.6.2 Randox Business Overview
  • 7.6.3 Randox Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.6.4 Randox Drugs of Abuse Testing Products Offered
  • 7.6.5 Randox Recent Development
• 7.7 OraSure
  • 7.7.1 OraSure Company Information
  • 7.7.2 OraSure Business Overview
  • 7.7.3 OraSure Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.7.4 OraSure Drugs of Abuse Testing Products Offered
  • 7.7.5 OraSure Recent Development
• 7.8 Draeger
  • 7.8.1 Draeger Company Information
  • 7.8.2 Draeger Business Overview
  • 7.8.3 Draeger Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.8.4 Draeger Drugs of Abuse Testing Products Offered
  • 7.8.5 Draeger Recent Development
• 7.9 InTec
  • 7.9.1 InTec Company Information
  • 7.9.2 InTec Business Overview
  • 7.9.3 InTec Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.9.4 InTec Drugs of Abuse Testing Products Offered
  • 7.9.5 InTec Recent Development
• 7.10 Orient Gene
  • 7.10.1 Orient Gene Company Information
  • 7.10.2 Orient Gene Business Overview
  • 7.10.3 Orient Gene Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.10.4 Orient Gene Drugs of Abuse Testing Products Offered
  • 7.10.5 Orient Gene Recent Development
• 7.11 Hangzhou Biotest
  • 7.11.1 Hangzhou Biotest Company Information
  • 7.11.2 Hangzhou Biotest Business Overview
  • 7.11.3 Hangzhou Biotest Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.11.4 Hangzhou Biotest Drugs of Abuse Testing Products Offered
  • 7.11.5 Hangzhou Biotest Recent Development
• 7.12 Assure Tech
  • 7.12.1 Assure Tech Company Information
  • 7.12.2 Assure Tech Business Overview
  • 7.12.3 Assure Tech Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.12.4 Assure Tech Drugs of Abuse Testing Products Offered
  • 7.12.5 Assure Tech Recent Development
• 7.13 Aotai Bio
  • 7.13.1 Aotai Bio Company Information
  • 7.13.2 Aotai Bio Business Overview
  • 7.13.3 Aotai Bio Drugs of Abuse Testing Sales, Revenue and Gross Margin (2020-2025)
  • 7.13.4 Aotai Bio Drugs of Abuse Testing Products Offered
  • 7.13.5 Aotai Bio Recent Development

8 Drugs of Abuse Testing Manufacturing Cost Analysis

• 8.1 Drugs of Abuse Testing Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Drugs of Abuse Testing
• 8.4 Drugs of Abuse Testing Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Drugs of Abuse Testing Distributors List
• 9.3 Drugs of Abuse Testing Customers

10 Drugs of Abuse Testing Market Dynamics

• 10.1 Drugs of Abuse Testing Industry Trends
• 10.2 Drugs of Abuse Testing Market Drivers
• 10.3 Drugs of Abuse Testing Market Challenges
• 10.4 Drugs of Abuse Testing Market Restraints

11 Research Findings and Conclusion

12 Appendix

• 12.1 Research Methodology
  • 12.1.1 Methodology/Research Approach
    • 12.1.1.1 Research Programs/Design
    • 12.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 12.1.2 Data Source
    • 12.1.2.1 Secondary Sources
    • 12.1.2.2 Primary Sources
• 12.2 Author Details
• 12.3 Disclaimer

List of Tables

Table 1. Global Drugs of Abuse Testing Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Drugs of Abuse Testing Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Drugs of Abuse Testing Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Drugs of Abuse Testing Sales (K Units) by Region (2020-2025)

Table 5. Global Drugs of Abuse Testing Sales Market Share by Region (2020-2025)

Table 6. Global Drugs of Abuse Testing Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Drugs of Abuse Testing Revenue Share by Region (2020-2025)

Table 8. Global Drugs of Abuse Testing Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Drugs of Abuse Testing Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Drugs of Abuse Testing Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Drugs of Abuse Testing Revenue Share Forecast by Region (2026-2031)

Table 12. Global Drugs of Abuse Testing Sales by Type (K Units) & (2020-2025)

Table 13. Global Drugs of Abuse Testing Sales Share by Type (2020-2025)

Table 14. Global Drugs of Abuse Testing Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Drugs of Abuse Testing Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Drugs of Abuse Testing Sales by Type (K Units) & (2026-2031)

Table 17. Global Drugs of Abuse Testing Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Drugs of Abuse Testing Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Drugs of Abuse Testing Sales by Application (K Units) & (2020-2025)

Table 21. Global Drugs of Abuse Testing Sales Share by Application (2020-2025)

Table 22. Global Drugs of Abuse Testing Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Drugs of Abuse Testing Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Drugs of Abuse Testing Sales by Application (K Units) & (2026-2031)

Table 25. Global Drugs of Abuse Testing Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Drugs of Abuse Testing Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Drugs of Abuse Testing Application

Table 28. Global Drugs of Abuse Testing Sales by Company (K Units) & (2020-2025)

Table 29. Global Drugs of Abuse Testing Sales Share by Company (2020-2025)

Table 30. Global Drugs of Abuse Testing Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Drugs of Abuse Testing Revenue Share by Company (2020-2025)

Table 32. Global Drugs of Abuse Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Abuse Testing as of 2024)

Table 33. Global Market Drugs of Abuse Testing Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Drugs of Abuse Testing, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Drugs of Abuse Testing, Product Type & Application

Table 36. Global Key Manufacturers of Drugs of Abuse Testing, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Drugs of Abuse Testing Sales by Company (2020-2025) & (K Units)

Table 39. North America Drugs of Abuse Testing Sales Market Share by Company (2020-2025)

Table 40. North America Drugs of Abuse Testing Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Drugs of Abuse Testing Revenue Market Share by Company (2020-2025)

Table 42. North America Drugs of Abuse Testing Sales by Type (2020-2025) & (K Units)

Table 43. North America Drugs of Abuse Testing Sales Market Share by Type (2020-2025)

Table 44. North America Drugs of Abuse Testing Sales by Application (2020-2025) & (K Units)

Table 45. North America Drugs of Abuse Testing Sales Market Share by Application (2020-2025)

Table 46. Europe Drugs of Abuse Testing Sales by Company (2020-2025) & (K Units)

Table 47. Europe Drugs of Abuse Testing Sales Market Share by Company (2020-2025)

Table 48. Europe Drugs of Abuse Testing Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Drugs of Abuse Testing Revenue Market Share by Company (2020-2025)

Table 50. Europe Drugs of Abuse Testing Sales by Type (2020-2025) & (K Units)

Table 51. Europe Drugs of Abuse Testing Sales Market Share by Type (2020-2025)

Table 52. Europe Drugs of Abuse Testing Sales by Application (2020-2025) & (K Units)

Table 53. Europe Drugs of Abuse Testing Sales Market Share by Application (2020-2025)

Table 54. China Drugs of Abuse Testing Sales by Company (2020-2025) & (K Units)

Table 55. China Drugs of Abuse Testing Sales Market Share by Company (2020-2025)

Table 56. China Drugs of Abuse Testing Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Drugs of Abuse Testing Revenue Market Share by Company (2020-2025)

Table 58. China Drugs of Abuse Testing Sales by Type (2020-2025) & (K Units)

Table 59. China Drugs of Abuse Testing Sales Market Share by Type (2020-2025)

Table 60. China Drugs of Abuse Testing Sales by Application (2020-2025) & (K Units)

Table 61. China Drugs of Abuse Testing Sales Market Share by Application (2020-2025)

Table 62. Japan Drugs of Abuse Testing Sales by Company (2020-2025) & (K Units)

Table 63. Japan Drugs of Abuse Testing Sales Market Share by Company (2020-2025)

Table 64. Japan Drugs of Abuse Testing Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Drugs of Abuse Testing Revenue Market Share by Company (2020-2025)

Table 66. Japan Drugs of Abuse Testing Sales by Type (2020-2025) & (K Units)

Table 67. Japan Drugs of Abuse Testing Sales Market Share by Type (2020-2025)

Table 68. Japan Drugs of Abuse Testing Sales by Application (2020-2025) & (K Units)

Table 69. Japan Drugs of Abuse Testing Sales Market Share by Application (2020-2025)

Table 70. Abbott Company Information

Table 71. Abbott Description and Business Overview

Table 72. Abbott Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Abbott Drugs of Abuse Testing Product

Table 74. Abbott Recent Development

Table 75. Thermo Fisher Company Information

Table 76. Thermo Fisher Description and Business Overview

Table 77. Thermo Fisher Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Thermo Fisher Drugs of Abuse Testing Product

Table 79. Thermo Fisher Recent Development

Table 80. Roche Company Information

Table 81. Roche Description and Business Overview

Table 82. Roche Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Roche Drugs of Abuse Testing Product

Table 84. Roche Recent Development

Table 85. Siemens Healthineers Company Information

Table 86. Siemens Healthineers Description and Business Overview

Table 87. Siemens Healthineers Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Siemens Healthineers Drugs of Abuse Testing Product

Table 89. Siemens Healthineers Recent Development

Table 90. Wondfo Biotech Company Information

Table 91. Wondfo Biotech Description and Business Overview

Table 92. Wondfo Biotech Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Wondfo Biotech Drugs of Abuse Testing Product

Table 94. Wondfo Biotech Recent Development

Table 95. Randox Company Information

Table 96. Randox Description and Business Overview

Table 97. Randox Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Randox Drugs of Abuse Testing Product

Table 99. Randox Recent Development

Table 100. OraSure Company Information

Table 101. OraSure Description and Business Overview

Table 102. OraSure Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. OraSure Drugs of Abuse Testing Product

Table 104. OraSure Recent Development

Table 105. Draeger Company Information

Table 106. Draeger Description and Business Overview

Table 107. Draeger Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Draeger Drugs of Abuse Testing Product

Table 109. Draeger Recent Development

Table 110. InTec Company Information

Table 111. InTec Description and Business Overview

Table 112. InTec Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. InTec Drugs of Abuse Testing Product

Table 114. InTec Recent Development

Table 115. Orient Gene Company Information

Table 116. Orient Gene Description and Business Overview

Table 117. Orient Gene Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Orient Gene Drugs of Abuse Testing Product

Table 119. Orient Gene Recent Development

Table 120. Hangzhou Biotest Company Information

Table 121. Hangzhou Biotest Description and Business Overview

Table 122. Hangzhou Biotest Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Hangzhou Biotest Drugs of Abuse Testing Product

Table 124. Hangzhou Biotest Recent Development

Table 125. Assure Tech Company Information

Table 126. Assure Tech Description and Business Overview

Table 127. Assure Tech Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Assure Tech Drugs of Abuse Testing Product

Table 129. Assure Tech Recent Development

Table 130. Aotai Bio Company Information

Table 131. Aotai Bio Description and Business Overview

Table 132. Aotai Bio Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Aotai Bio Drugs of Abuse Testing Product

Table 134. Aotai Bio Recent Development

Table 135. Production Base and Market Concentration Rate of Raw Material

Table 136. Key Suppliers of Raw Materials

Table 137. Drugs of Abuse Testing Distributors List

Table 138. Drugs of Abuse Testing Customers List

Table 139. Drugs of Abuse Testing Market Trends

Table 140. Drugs of Abuse Testing Market Drivers

Table 141. Drugs of Abuse Testing Market Challenges

Table 142. Drugs of Abuse Testing Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Drugs of Abuse Testing Product Picture

Figure 2. Global Drugs of Abuse Testing Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Drugs of Abuse Testing Sales Market Share by Type in 2024 & 2031

Figure 4. Urine Testing Product Picture

Figure 5. Saliva Testing Product Picture

Figure 6. Blood Testing Product Picture

Figure 7. Hair and Sweat Testing Product Picture

Figure 8. Others Product Picture

Figure 9. Global Drugs of Abuse Testing Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 10. Global Drugs of Abuse Testing Sales Market Share by Application in 2024 & 2031

Figure 11. Hospital Examples

Figure 12. Law Enforcement Examples

Figure 13. Drug Treatment Center Examples

Figure 14. Laboratory Examples

Figure 15. Others Examples

Figure 16. Global Drugs of Abuse Testing Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Drugs of Abuse Testing Sales Growth Rate (2020-2031) & (US$ Million)

Figure 18. Global Drugs of Abuse Testing Sales (K Units) Growth Rate (2020-2031)

Figure 19. Global Drugs of Abuse Testing Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 20. Drugs of Abuse Testing Report Years Considered

Figure 21. Global Market Drugs of Abuse Testing Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 22. Global Drugs of Abuse Testing Revenue Market Share by Region: 2020 VS 2024

Figure 23. North America Drugs of Abuse Testing Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. North America Drugs of Abuse Testing Sales (K Units) Growth Rate (2020-2031)

Figure 25. Europe Drugs of Abuse Testing Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. Europe Drugs of Abuse Testing Sales (K Units) Growth Rate (2020-2031)

Figure 27. China Drugs of Abuse Testing Revenue (US$ Million) Growth Rate (2020-2031)

Figure 28. China Drugs of Abuse Testing Sales (K Units) Growth Rate (2020-2031)

Figure 29. Japan Drugs of Abuse Testing Revenue (US$ Million) Growth Rate (2020-2031)

Figure 30. Japan Drugs of Abuse Testing Sales (K Units) Growth Rate (2020-2031)

Figure 31. Global Drugs of Abuse Testing Revenue Share by Type (2020-2025)

Figure 32. Global Drugs of Abuse Testing Sales Share by Type (2026-2031)

Figure 33. Global Drugs of Abuse Testing Revenue Share by Type (2026-2031)

Figure 34. Global Drugs of Abuse Testing Revenue Share by Application (2020-2025)

Figure 35. Global Drugs of Abuse Testing Revenue Growth Rate by Application in 2020 & 2024

Figure 36. Global Drugs of Abuse Testing Sales Share by Application (2026-2031)

Figure 37. Global Drugs of Abuse Testing Revenue Share by Application (2026-2031)

Figure 38. Global Drugs of Abuse Testing Sales Share by Company (2024)

Figure 39. Global Drugs of Abuse Testing Revenue Share by Company (2024)

Figure 40. Global 5 Largest Drugs of Abuse Testing Players Market Share by Revenue in Drugs of Abuse Testing: 2020 & 2024

Figure 41. Drugs of Abuse Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 42. Manufacturing Cost Structure of Drugs of Abuse Testing

Figure 43. Manufacturing Process Analysis of Drugs of Abuse Testing

Figure 44. Drugs of Abuse Testing Industrial Chain

Figure 45. Channels of Distribution (Direct Vs Distribution)

Figure 46. Distributors Profiles

Figure 47. Bottom-up and Top-down Approaches for This Report

Figure 48. Data Triangulation

Figure 49. Key Executives Interviewed